linjc16/ctgov huggingface dataset:
Shoulder Endurance Assessment in Upper Limb Athletes

Study Overview
=================
Brief Summary
-----------------
The objective of this study is to explore the relationship between two different fatigue tests (Xco Endurance Test and Shoulder Endurance Test) and strength/endurance of shoulder rotators muscles, measured with an isokinetic device. The tests will be organized during two different sessions, in a randomized order. One session will be dedicated to isokinetic evaluation. The other one will include the performance of the two functional tests.

Official Title
-----------------
Relation Between Different Tests Aimed to Assess Shoulder Endurance in Upper Limb Athletes

Conditions
-----------------
Strength and Endurance

Intervention / Treatment
-----------------
* Other: Realization of the 3 tests


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Age between 18 and 28 years To practice an overhead sports, at least 5 hours a week Exclusion Criteria: Any shoulder surgery history Any shoulder pain Any shoulder injury during the last 6 months

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 28 Years

Sexes Eligible for Study
-----------------
Male

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: Realization of the 3 tests|The participants will have to perform the isokinetic evaluation during one session and the two functional tests during another session. Those sessions will be separated by 14 days.|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Shoulder rotators strength | Shoulder rotators strength (IR, ER) will be measured with isokinetic dynamometer | through study completion, 6 months | 
| Shoulder rotators work | Shoulder rotators work (IR, ER) will be measured with isokinetic dynamometer | through study completion, 6 months | 
| Shoulder Endurance Test | Time until exhaustion (in seconds) will be measured | through study completion, 6 months | 
| Xco Endurance Test | Time until exhaustion (in seconds) will be measured | through study completion, 6 months |
A Prospective Study of Traumatic Eye Injuries in the Period From January 2022 to June 2022 in Sohag University Hospitals

Study Overview
=================
Brief Summary
-----------------
Ocular trauma is one of the main causes of severe ocular morbidity. It represents a serious public health problem and leading cause of visual impairment. It is an important and preventable cause of visual impairment in both developing and developed countries.

Official Title
-----------------
A Prospective Study of Traumatic Eye Injuries in the Period From January 2022 to June 2022 in Sohag University Hospitals

Conditions
-----------------
Eye Injuries

Intervention / Treatment
-----------------
* Other: Statistics


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: All diagnosed cases of eye trauma, regardless of gender, laterality, duration of presentation and other chronic systemic illness Exclusion Criteria: patients with previous history of eye trauma or other pathological condition affecting visual acuity
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: Statistics|Study and analyze the medicolegal aspects of different eye trauma cases ( patterns of injuries, mechanisms, causes, site of trauma and outcome)|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Evaluate eye trauma cases at Sohag University Hospitals through statistical methods | We will analyze data about participants, mechanism of injuries, site of trauma and if the time of arrival if delayed or certain treatment will affect the outcome and then we will determine the causes of better outcome to improve the outcome of future cases | 6 months |
Study Evaluating Safety & Immunogenicity of rLP2086 Vaccine in Adolescents

Study Overview
=================
Brief Summary
-----------------
Study to evaluate the safety of an investigational meningitis vaccine and the immune response to it in adolescents

Official Title
-----------------
A Randomized, Observer-blinded, Parallel-group, Active-control, Phase ½ Trial Of The Safety, Immunogenicity, And Tolerability Of 20 Mg, 60 Mg, And 200 Mg Of Meningococcal Group B Rlp2086 Vaccine In Healthy Children And Adolescents Aged 8 To 14 Years

Conditions
-----------------
Healthy

Intervention / Treatment
-----------------
* Biological: rLP2086
* Biological: rLP2086
* Biological: rLP2086
* Biological: rLP2086


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Inclusion Criteria Aged 8 to 14 years at the time of enrollment. Healthy male or female subjects Negative urine pregnancy test for female subjects Exclusion Criteria: Exclusion Criteria Prior vaccination with a meningococcal B vaccine Prior meningococcal disease

Ages Eligible for Study
-----------------
Minimum Age: 8 Years
Maximum Age: 14 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Prevention
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Group A<br>20ug Experimental | Biological: rLP2086<br>* Vaccine administered at 0, 1, and 6 months<br>|
| Experimental: Group 2<br>60ug Experimental | Biological: rLP2086<br>* Vaccine administered at 0, 1, and 6 months<br>|
| Experimental: Group 3<br>200ug Experimental | Biological: rLP2086<br>* Vaccine administered at 0, 1, and 6 months<br>|
| Active Comparator: Group 4<br>Active comparator | Biological: rLP2086<br>* Vaccine administered at 0, 1, and 6 months<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Percentage of Participants With Seroconversion in rLP2086 Specific Serum Bactericidal Assay (SBA) Titer 1 Month After Dose 2 |  | 1 month after Dose 2 | 
| Percentage of Participants With Seroconversion in rLP2086 Specific SBA Titer 1 Month After Dose 3 |  | 1 month after Dose 3 | 
| Percentage of Participants With at Least One Adverse Event (AE) |  | Dose 1 up to 1 month after Dose 3 | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Adolescent, Meningococcal, Safety
Chronic Pain After Video-assisted Thoracoscopic Surgery (VATS) Surgery for Pneumothorax

Study Overview
=================
Brief Summary
-----------------
The study will investigate characteristics of chronic pain after VATS surgery with two different sizes of videoscopic equipment.

Official Title
-----------------
Chronic Pain After VATS Surgery for Pneumothorax

Conditions
-----------------
Pneumothorax

Intervention / Treatment
-----------------
* Device: 5mm videoscope
* Device: 10mm videoscope


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: PSP Able to understand and give consent Can read Residing in Denmark Exclusion Criteria: Unable to understand the written information in Danish Abuse (Medicine, Drugs, Alcohol) Severe psychiatric Illness Conflicting neurological disease Conversion to open surgery Use of neuroaxial analgesia Use of electric cauterizer necessitated Additional thoracic surgery in the investigation period

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 40 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Prevention
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: 5 mm equipment<br>5 mm videoscopic equipment | Device: 5mm videoscope<br>* use of 5mm videoscope<br>|
| Experimental: 10 mm<br>Use of standard 10 mm VATS equipment | Device: 10mm videoscope<br>* use of 10mm videoscope<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| QST score |  | 2 years | 
| Post surgical pain |  | 2 years | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Patient related factors, depression, coping etc. |  | 2 years | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
persistent pain, neuropathic pain, Chronic Pain, VATS, Primary spontaneous pneumothorax patients
Evaluation of the Prognostic Value of T7 and T12 Slices on Mortality in Resuscitation Patients With ARDS Caused by SARS-COV2 Infection

Study Overview
=================
Brief Summary
-----------------
Sarcopenia is a risk factor for adverse outcome in critically ill patients. Sarcopenia might be estimated from muscle surface measure on tomodensitometry. The purpose of the study is to identify if muscle surfaces measured on thoracic tomodensitometry are associated with mortality in patients with acute respiratory distress syndrome due to SARS-Cov-2.

Official Title
-----------------
Evaluation of the Prognostic Value of T7 and T12 Slices on Mortality in Resuscitation Patients With ARDS Caused by SARS-COV2 Infection

Conditions
-----------------
Acute Respiratory Distress Syndrom (SARS-Cov 2)

Intervention / Treatment
-----------------
* Other: Data collection
* Other: analysis of thoracic scans


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: patients hospitalized in intensive care for SARS-Cov-2 infection since january 2020 Thoracic TDM within the 30 day preceding ICU admission and up to 24 hours after ICU admission Exclusion Criteria: Pregnancy Neuromuscular disease

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| 28-day survival<br>Alive 28 days after intensive care admission | Other: Data collection<br>* Demographic data: Age, Sex, weight, height, main history and treatments. - Biological data: CRP, PCT, albumin, pre-albumin<br>Other: analysis of thoracic scans<br>* muscle area calculated on the T7 and T12 thoracic slices<br>|
| 28-day death<br>Deceased 28 days after intensive care admission | Other: Data collection<br>* Demographic data: Age, Sex, weight, height, main history and treatments. - Biological data: CRP, PCT, albumin, pre-albumin<br>Other: analysis of thoracic scans<br>* muscle area calculated on the T7 and T12 thoracic slices<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| measurement of muscle area at T7 level indexed in cm²/m². | use of CT measurements to discriminate between the 2 groups (deceased versus alive) | At hospital admission | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Duration of mechanical ventilation |  | within the 28 days | 
| Ventilator free days |  | within the 28 days | 
| number of days in Intensive care unit |  | within the 28 days | 
| number of days in hospital |  | within the 28 days |
Intravenous Fluids After Laparoscopic Cholecystectomy

Study Overview
=================
Brief Summary
-----------------
Perioperative intravenous fluid (IV) administration has been the standard procedure since 1832 and, is a widely used practice sometimes under inadequate criteria. The present work aims at verifying the clinical need that justifies the common IV fluid prescription on the postoperative (PO) period in patients undergoing videolaparoscopic cholecystectomy (CVL) elective.

Detailed Description
-----------------
Patients undergoing elective laparoscopy cholecystectomies were randomized to either routine practice fluid prescription (control group) or no IV fluids in the postoperative period. Thirst, hunger, presence of nausea and vomiting, renal function and personal satisfaction were assessed. Body composition was evaluated by bioimpedance

Official Title
-----------------
Intravenous Fluids After Laparoscopic Cholecystectomy: Necessary or Dispensable. A Randomized Clinical Trial

Conditions
-----------------
Hunger, Postoperative Nausea, Postoperative Vomiting, Renal Function Abnormal, Thirst, Fluid Electrolyte Disorders

Intervention / Treatment
-----------------
* Other: Suspension of the IV fluids


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Elective laparoscopy cholescitectomy; no intraoperative complication - Exclusion Criteria: Co-existing severe renal failure, cardiac failure or pulmonary disease -

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Interventional Model Description: Controls - convention postoperative IV fluids; intervention arm - no IV fluids postoperative
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| No Intervention: IV fluids<br>Regular IV fluids (Glucose 5% and Sodium Chloride 10% or Ringer) at the surgeon description | |
| Experimental: No IV fluids<br>No IV fluids after the termination of the operation. T | Other: Suspension of the IV fluids<br>* No IV fluids prescription, IV catheter filled with saline solution<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Renal function | Serum creatinine | 24 hours | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Presence of thirst | Visual analog scale | 24 hours | 
| Presence of nausea | Visual analog scale | 24 hours | 
| Total intravenous prescribed fluids per body weight |  | 24 hours | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
saline solution, laparoscopy, cholecystectomy, outcomes
Evaluating Taste and Smell Function and Food and Taste Preferences of Head and Neck Cancer Patients During Radiation Therapy/Chemotherapy

Study Overview
=================
Brief Summary
-----------------
Changes to taste and smell have been reported in head and neck cancer patients who undergo radiation and chemotherapy. This may cause food to be unappealing and can lead to a reduced food intake. Thsi study will increase our understanding of taste and smell changes and how it relates to food and taste preferences.

Official Title
-----------------
Evaluation of Chemosensory Function and Taste Preference of Head and Neck Cancer Patients Prior to, On Completion of and Six Weeks After Oncology Treatment

Conditions
-----------------
Head and Neck Cancer

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: 18 years or older diagnosed with head and neck cancer including the lip, oral cavity, salivary glands, paranasal sinuses, oropharynx, hypopharynx, larynx and thyroid all histologic types of cancer all tumour stages according to American Joint Committee for Cancer (AJCC) Staging all forms of RT including standard or investigational and/or concurrent standard or investigational chemotherapy for head and neck cancers alert and mentally competent English speaking Exclusion Criteria: unable to swallow unwilling to participate

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
diet, food, taste, smell, head and neck, radiation, chemotherapy
Evaluation of Two Silicone Hydrogel Lenses Over a One Month Period

Study Overview
=================
Brief Summary
-----------------
The purpose of this trial is to compare two different contact lenses during 4 weeks of wear.

Official Title
-----------------
Evaluation of Two Silicone Hydrogel Lenses Over a One Month Period

Conditions
-----------------
Myopia

Intervention / Treatment
-----------------
* Device: Lotrafilcon A contact lens
* Device: Comfilcon A contact lens


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Current soft contact lens wearer who wear their habitual lenses for no less than 10 hours a day, 5 days a week Have a need for correction in both eyes and be correctable to at least 20/40 distance vision in each eye while wearing trial lenses Replace lenses on a weekly or longer schedule Other protocol inclusion/exclusion criteria may apply Exclusion Criteria: Requires concurrent ocular medication Eye injury or surgery within twelve weeks immediately prior to enrollment Evidence of systemic or ocular abnormality, infection, or disease likely to affect successful wear of contact lenses or use of their accessory solutions Current soft toric lens wearers Those who dispose of their soft lenses on a daily basis Current NIGHT & DAY® or Biofinity® lens wearers Other protocol-defined inclusion/exclusion criteria may apply

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Lotrafilcon A<br>Investigational, spherical, silicone hydrogel contact lenses | Device: Lotrafilcon A contact lens<br>* Silicone hydrogel contact lens<br>|
| Active Comparator: Comfilcon A<br>Commercially marketed, spherical, silicone hydrogel contact lenses | Device: Comfilcon A contact lens<br>* Silicone hydrogel contact lens<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Comfort at End of Day | Evaluated by the subject as a single, retrospective evaluation of 4-week wear time. Measured on a 10-point scale, with 1 being poor and 10 being excellent. | After 4 weeks of wear |
Retrospective Review of Anesthetic Considerations for Pulmonary Artery Rehabilitation

Study Overview
=================
Brief Summary
-----------------
Pulmonary artery rehabilitation procedure is done frequently in the catheterization suite for patients with pulmonary artery stenosis or small pulmonary arteries following surgical repair for patients with tetralogy of Fallot with pulmonary atresia and major aortopulmonary collaterals. Considering that the investigators' institution is a major center for treating these cases, the investigators wanted to do a retrospective review of the investigators' data to share the investigators' anesthetic management of these procedures.

Conditions
-----------------
Pulmonary Artery Stenosis, Tetralogy of Fallot, Pulmonary Atresia

Intervention / Treatment
-----------------
* Procedure: Pulmonary artery rehabilitation


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients who underwent pulmonary artery angioplasty during the period between October 1st 2010 and October 1st 2015 at NCH. Exclusion Criteria: None
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Pulmonary artery rehabilitation<br>Patients with pulmonary artery stenosis or small pulmonary arteries following surgical repair for tetralogy of Fallot with pulmonary atresia and major aortopulmonary collaterals undergoing cardiac catheterization. | Procedure: Pulmonary artery rehabilitation<br> <br> |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of patients who experience hemorrhage |  | During catheterization procedure. |
Analysis of Urogenital Injuries in Polytraumatized Patients

Study Overview
=================
Brief Summary
-----------------
Urogenital injuries occur in approximately 5-10 % of all severly injured patients. The literature lacks a thorough investigation into the mechanisms of trauma, the analysis of the whole urogenital tract and especially the correlation of thoracic and lumbar spine and pelvic injuries with urogenital injuries. The goal of this study is to provide a thorough investigation into these primary end points in a multicenter study of university hospitals in Germany.

Official Title
-----------------
Injuries of the Urogenital Tract in Polytraumatized Patients in Correlation With Injuries to the Spine and Pelvic Girdle- Are There Positive Predictive Factors

Conditions
-----------------
Polytrauma

Intervention / Treatment
-----------------
* Other: retrospective analysis


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: ISS (Injury severity score) > 15 points Patient Age > 16 Fracture of the thoracic and/ or lumbar spine Fracture of the pelvic girdle at least one AIS (abbreviated injury scale) > 2 Exclusion Criteria: ISS < 16 points no fractures of the thoracic or lumbar spine or fractures of the pelvic girdle no AIS > 2 patient age under 16 years of age

Ages Eligible for Study
-----------------
Minimum Age: 16 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| 1<br>Patients with urogenital injuries | Other: retrospective analysis<br> <br> |
| 2<br>Patients without urogenital injuries | Other: retrospective analysis<br> <br> |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Predictive factors for urogenital injuries | This retrospective analysis is designed to identify predictors of urogenital injuries in polytrauma patients | 5 years |